Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

SODIUM SULFACETAMIDE 10% WASH

SODIUM SULFACETAMIDE
$0.2210per ML

Strength

100 mg/mL

Manufacturer

Acella Pharmaceuticals, LLC

NDC

42192012916

Classification

Generic

Dosage Form

LIQUID

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

SULFACETAMIDE SODIUM

Approval Type

Unapproved

On Market Since

1/4/2011

Pharmacological Classes

Sulfonamide Antibacterial
Sulfonamides

Price History

1W

0.0%

1M

-5.9%

3M

-13.7%

6M

-11.1%

1Y

-18.4%

3Y

N/A

5Y

N/A

All

+20.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

SULFAMETHOXAZOLE-TMP SS TABLET
Generic
60687060365•American Health Packaging
$0.0385
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
50268072815•AvPAK
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
53746027105•Amneal Pharmaceuticals of New York LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
57237023201•Rising Pharma Holdings Inc.
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
57237023205•Rising Pharma Holdings Inc.
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
62135089718•Chartwell RX LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
62135089790•Chartwell RX LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
65162027110•Amneal Pharmaceuticals LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
65162027150•Amneal Pharmaceuticals LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
65862041901•Aurobindo Pharma Limited
$0.0394
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy